SAB BIOTHERAPEUTICS, INC. Public Float
SAB BIOTHERAPEUTICS, INC. (SABS) had Public Float of $76.73 million as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $76.73M.
- 2024-06-30: Entity Public Float $19.54M.
- 2023-06-30: Entity Public Float $30.70M.
- 2022-06-30: Entity Public Float $32.74M; Entity Public Float as first filed $14.54M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $76.73M 10-K · filed 2026-03-09 | |
| 2024-06-30 | $19.54M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $30.70M 10-K · filed 2024-03-29 | |
| 2022-06-30 | $32.74M 10-K/A · filed 2023-04-28 | $14.54M 10-K · filed 2023-04-14 |
| 2021-06-30 | $114.54M 10-K/A · filed 2023-04-28 | |
| 2020-06-30 | $0.00 10-K · filed 2021-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |